CUTERA INC: Nasdaq/NYSE listing notice — Cutera receives Nasdaq deficiency notice for delayed 2022 annual report; must submit compliance plan by May 22

CUTERA INC

Nasdaq notified Cutera on March 21, 2023 of non-compliance for failing to file 2022 10-K by March 16, 2023 extended due date.
Company has 60 days, until May 22, 2023, to submit a plan to regain compliance under Nasdaq Listing Rule 5250(c)(1).
If plan accepted, Nasdaq may grant an exception until September 12, 2023 to file the overdue annual report.
Cutera states it is working diligently to complete and file the Form 10-K as soon as practicable; listing not immediately affected.
Previous inability to file was disclosed in a Form 12b-25 filed on March 16, 2023.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

CUTERA INC received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

March 21, 2023, Cutera, Inc. (the ”Company”) received a notification letter (the “Notice”) from The Nasdaq Stock Market (“Nasdaq”) stating that, because the Company has not yet filed its Annual Report on Form 10-K for the year ended December 31, 2022, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires Nasdaq-listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission. The Notice has no immediate effect on the listing or trading of the Company’s securities. Nasdaq has informed the Company

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001193125-23-079289

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.